Physician

Albert B. Sun, M.D.

According to 2025 Medicare claims, Albert Sun, M.D. (NPI: 1336192913) practices endocrinology in the Atlantic City-Hammonton, NJ market, with the plurality of this provider's patient population coming from Atlantic, NJ. This provider's primary affiliated billing organization is ATLANTICARE PHYSICIAN GROUP PA (NPI: 1093829608; TIN: 020701782) and primary practice location at 08234-9998. Sun is affiliated with the AtlantiCare Health Solutions, Inc. (ACO ID: A4516), participating under the MSSP model.

Sun's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 275 traditional Medicare patients, billed 840 HCPCS/CPT codes, and received $62,693 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 2,431 prescription claims across 451 beneficiaries totaling $1,518,855 in drug costs, led by Ozempic (Semaglutide). DME data shows 326 claims. Open Payments data shows 69 records totaling $1,955. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $547,667 to $1,518,855. For DME billing, reported payments moved sharply higher in recent years, from $2,228 to $111,206.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	584	879	$48,764
2016	524	721	$36,199
2017	450	594	$31,710
2018	439	566	$28,308
2019	738	8,152	$221,270
2020	592	8,026	$205,348
2021	611	10,303	$265,426
2022	669	11,339	$270,327
2023	561	4,010	$109,811
2024	275	840	$62,693

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	326	1,993	$547,667
2016	386	2,499	$589,525
2017	413	2,455	$617,355
2018	407	2,719	$826,260
2019	733	4,170	$1,427,864
2020	566	5,058	$2,015,006
2021	585	5,495	$2,521,386
2022	647	6,045	$2,852,184
2023	743	4,354	$2,317,645
2024	451	2,431	$1,518,855

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	121	264	$6,087
2016	100	305	$9,735
2017	101	342	$13,469
2018	115	360	$16,143
2019	194	351	$16,946
2020	258	673	$36,395
2021	281	910	$100,382
2022	268	1,153	$168,346
2023	210	987	$150,814
2024	121	326	$104,387

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	52	52	$127
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	197	397	$95
95251	Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report	36	57	$27
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	71	76	$14
83036	Hemoglobin a1c level	75	92	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	295	14,100	$451,292
Jardiance	Empagliflozin	184	11,016	$209,809
Trulicity	Dulaglutide	88	4,146	$137,299
Mounjaro	Tirzepatide	82	3,472	$119,841
Farxiga	Dapagliflozin Propanediol	91	5,238	$96,353

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	64	193	$98,768
E0784	External ambulatory infusion pump, insulin	Y	N/R	11	$3,514
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	33	65	$1,166
A4225	Supplies for external insulin infusion pump, syringe type cartridge, sterile, each	N	N/R	11	$849
A4259	Lancets, per box of 100	N	24	33	$51

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	69	$1,955	Biosense Webster, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Albert B. Sun, M.D.?

Tedicare shows public-source Medicare data for Albert B. Sun, M.D. (NPI 1336192913), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Albert B. Sun, M.D. have ACO affiliation data?

Albert B. Sun, M.D. is shown with ACO affiliation data for AtlantiCare Health Solutions, Inc. (MSSP, ACO ID A4516).

What billing organization is linked to Albert B. Sun, M.D.?

Albert B. Sun, M.D. is linked to ATLANTICARE PHYSICIAN GROUP PA (billing NPI 1093829608) in the available physician profile data.

Does Albert B. Sun, M.D. have Open Payments data?

Albert B. Sun, M.D. has 69 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.